デジタル治療(DTx)市場:提供製品別(プラットフォーム、バーチャルリアリティ/ゲーム)、収益モデル別(サブスクリプション、バリューベース)、用途別(治療(糖尿病、肥満、中枢神経系、呼吸器系、CVD)、薬物アドヒアランス、リハビリ/患者ケア)-2028年までの世界予測Digital Therapeutics (DTx) Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) - Global Forecast to 2028 デジタル治療薬市場は、予測期間中の年平均成長率29.1%で、2023年の61億米ドルから2028年には219億米ドルに達すると予測されている。デジタル治療薬の急速な普及は、慢性疾患と闘う患者数の増加や、この分野への... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーデジタル治療薬市場は、予測期間中の年平均成長率29.1%で、2023年の61億米ドルから2028年には219億米ドルに達すると予測されている。デジタル治療薬の急速な普及は、慢性疾患と闘う患者数の増加や、この分野への投資の拡大といった要因に後押しされている。とはいえ、市場成長の阻害要因としては、発展途上国におけるデジタル治療プログラムへの認識やアクセスの不足、従来の医療提供者の抵抗、不均等な支払いモデルの存在などが挙げられる。"サブスクリプションベースの収益モデルセグメントは、予測期間中、市場で最大かつ最も急成長しているカテゴリーである。" デジタル治療薬市場の収益モデルセグメントは、サブスクリプション、一括購入/ライセンス、成果/価値ベースに分類される。2022年には、サブスクリプションセグメントが最大の市場シェアを占めた。デジタル治療薬は長期的な健康成果を目指すことが多く、ユーザーは長期にわたってプログラムにコミットする必要がある。サブスクリプションモデルは、インセンティブやプラットフォームの機能への継続的なアクセスを提供することで、ユーザーのコミットメントを促す。 "糖尿病分野は予測期間中に最も高い成長率が見込まれる" 治療/ケア関連アプリケーションの種類に関して、デジタル治療薬市場は糖尿病、中枢神経系疾患、慢性呼吸器疾患、筋骨格系疾患、心血管疾患、禁煙、服薬アドヒアランス、消化器疾患、薬物使用障害・中毒管理、リハビリテーション・患者ケア、その他の治療/ケア関連アプリケーションに分類される。 治療/ケア関連アプリケーションのカテゴリーでは、糖尿病分野が予測期間中に最も高い成長率を記録する見通しである。糖尿病におけるデジタル治療市場は、2022年に最大のシェアを占めた。推進要因としては、糖尿病の有病率の増加、糖尿病に関連する多額の医療費、費用対効果の高いソリューションによる負担軽減に焦点を当てた政府のイニシアチブの高まりなどが挙げられる。 「B2B分野は予測期間中に最も高いCAGRで成長する見込みである。 販売チャネルに関して、デジタル治療薬市場は企業対顧客(B2C)と企業対企業(B2B)に区分される。B2B分野は、予測期間中に最も高いCAGRを示すと予測され、その理由は、デジタル治療薬を医薬品と統合するために、製薬会社とデジタルヘルス企業とのパートナーシップが拡大しているためである。製薬企業は、デジタル治療薬プロバイダーとの戦略的提携や買収に積極的に取り組んでいる。これらの提携により、製薬会社はデジタル治療薬をより広範なヘルスケアソリューションに統合し、患者ケアに全体的なアプローチを提供することができる。さらに、保険会社や医療提供者を含む支払者は、価値ベースのケアモデルをますます受け入れている。デジタル・セラピューティクスは、アウトカム、予防、費用対効果を重視することで、こうしたモデルに合致している。支払者は、予防的介入を通じて医療費を削減するDTxの可能性を見ており、最終的に採用を促進している。 "北米が最大かつ最も急成長する地域市場になる" 米国とカナダで構成される北米は、2022年のデジタル治療薬市場で大きなシェアを占めている。技術進歩に資金を提供する政府の制度やデジタル治療薬に対する有利な償還構造などの要因が、この地域の市場成長を促進すると予測されている。また、北米の支払者や医療提供者は、デジタル治療薬の早期導入者である。同地域では、保険会社、医療提供者、その他の利害関係者がDTxの臨床効果と費用対効果を認識し、積極的に取り組んでいる。このような早期の賛同が、さまざまな医療環境での広範な採用を後押ししている。 本レポートのために実施した主なインタビューは以下のように分類される: - 企業タイプ別ティア1(50%)、ティア2(30%)、ティア3(20) - 役職別Cレベル(75%)、Dレベル(15%)、その他(10) - 地域別北米 (70%)、欧州 (20%)、APAC (7%)、RoW (3%) デジタル治療薬市場の主要プレーヤー 同市場の主要プレーヤーは、Noom, Inc.(米国)、Teladoc Health, Inc.(米国)、Omada Health, Inc.(米国)、WellDoc, Inc.(米国)、Biofourmis(米国)、Better Therapeutics, Inc.(米国)、Amalgm Rx社(米国)、CogniFit社(米国)、Headspace Health社(米国)、Propeller Health社(米国)、Virta Health Corp社(米国)、2Morrow社(米国)、Realizedcare社(米国)、Canary Health社(米国)、Twill社(米国)、Click Therapeutics社(米国)、Akili社(米国)、Cognoa社(米国)、Wellthy Therapeutics Pvt.(Ltd.(インド)、Kaia Health社(ドイツ)、Ayogo社(カナダ)、Mindable Health GmbH社(ドイツ)、Hinge Health社(米国)、Freespira社(米国)。 調査範囲 この調査レポートは、デジタル治療薬市場の質的および量的分析を掲載しています。本レポートの主な目的は、販売チャネル、収益モデル、用途、サービス、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することです。また、著名な市場プレイヤーの財務情報、最近の動向、企業プロフィール、最近の動向、市場戦略などとともに、広範な競合分析も含んでいます。 レポート購入の主な利点 本レポートは、デジタル治療薬市場全体とそのサブセグメント両方の収益数値の近似値を提供することで、市場リーダーや新規参入者を支援することを目的としています。関係者は本レポートを活用することで、競争環境を把握し、戦略的な事業ポジショニングのための洞察力を獲得し、効果的な市場参入戦略を策定することができます。さらに、市場ダイナミクスを評価する手段を関係者に提供し、重要な市場機会、阻害要因、促進要因、および課題に関する情報を提供します。 レポート購入の理由 本レポートは、既存企業だけでなく、新規参入企業や中小企業にとっても、市場の動向を把握する上で有益であり、ひいては市場シェアを拡大するのに役立つであろう。本レポートを購入された企業は、以下の戦略の1つまたは組み合わせを使用して、市場での地位を強化することができます。 本レポートは以下の洞察を提供する: 主な促進要因(予防可能な慢性疾患の罹患率の増加、予防医療への注目の高まり、医療費抑制の必要性、ベンチャーキャピタル投資の大幅な増加)、機会(新興市場における成長見込み、未診断・未治療の患者人口の多さ、予期せぬ治療用途)の分析が、デジタル治療薬市場の成長に影響を与えています。 製品開発/イノベーション:デジタル治療薬市場における今後の技術、研究開発活動、新製品発売に関する詳細な洞察。 市場開発:当レポートでは、さまざまな地域や国のデジタル治療薬市場を分析しています。 市場の多様化:デジタル治療薬市場における新しいソフトウェアやプログラム、未開拓の地域、最近の開発、投資に関する情報を網羅。 競合評価:本レポートは、市場における主要企業および主要中小企業/新興企業に関する詳細な洞察を提供します。成長戦略、市場シェア、プレイヤーの製品・サービス提供、市場の主要動向について詳細な評価を提供しています。本レポートにより、関係者はデジタル治療薬市場の動向を把握し、促進要因、課題、阻害要因、機会などの情報を得ることができます。 目次1 INTRODUCTION 401.1 STUDY OBJECTIVES 40 1.2 MARKET DEFINITION 40 1.3 INCLUSIONS AND EXCLUSIONS 40 1.4 MARKET SCOPE 41 1.4.1 MARKETS COVERED 41 1.4.2 YEARS CONSIDERED 42 1.4.3 CURRENCY CONSIDERED 42 1.5 STAKEHOLDERS 42 1.6 RESEARCH LIMITATIONS 43 1.7 SUMMARY OF CHANGES 43 1.8 RECESSION IMPACT 44 2 RESEARCH METHODOLOGY 45 2.1 RESEARCH DATA 45 FIGURE 1 RESEARCH DESIGN 45 2.1.1 SECONDARY DATA 46 2.1.1.1 Key data from secondary sources 47 2.1.2 PRIMARY DATA 47 FIGURE 2 PRIMARY SOURCES 47 2.1.2.1 Key data from primary sources 48 2.1.2.2 Key industry insights 49 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 50 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY TYPE OF BUYER AND REGION 50 2.2 MARKET SIZE ESTIMATION 51 2.2.1 BOTTOM-UP APPROACH 51 2.2.1.1 Approach 1: Revenue mapping-based estimation 51 FIGURE 5 DIGITAL THERAPEUTICS: REVENUE MAPPING-BASED ESTIMATION 52 2.2.1.2 Approach 2: Buyer adoption-based estimation 52 FIGURE 6 DIGITAL THERAPEUTICS ESTIMATION: BUYER ADOPTION-BASED ESTIMATION 52 2.2.2 TOP-DOWN APPROACH: PENETRATION RATE-BASED MARKET SIZE ESTIMATION 53 FIGURE 7 PENETRATION RATE-BASED MARKET ESTIMATION 53 2.2.3 GROWTH FORECAST 53 TABLE 1 IMPACT ANALYSIS 54 FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 55 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 56 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 56 FIGURE 10 DATA TRIANGULATION METHODOLOGY 57 2.4 ASSUMPTIONS 57 2.5 RISK ASSESSMENT 58 3 EXECUTIVE SUMMARY 59 FIGURE 11 DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2023 VS. 2028 (USD MILLION) 59 FIGURE 12 DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2023 VS. 2028 (USD MILLION) 60 FIGURE 13 DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60 FIGURE 14 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2023 VS. 2028 (USD MILLION) 61 FIGURE 15 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2023 VS. 2028 (USD MILLION) 62 FIGURE 16 GEOGRAPHICAL SNAPSHOT OF DIGITAL THERAPEUTICS MARKET 63 4 PREMIUM INSIGHTS 64 4.1 DIGITAL THERAPEUTICS MARKET OVERVIEW 64 FIGURE 17 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET 64 4.2 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2023 VS. 2O28 65 FIGURE 18 B2B SALES CHANNEL SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 65 4.3 DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66 FIGURE 19 US TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 66 5 MARKET OVERVIEW 67 5.1 INTRODUCTION 67 5.2 MARKET DYNAMICS 67 FIGURE 20 DIGITAL THERAPEUTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67 5.2.1 DRIVERS 68 5.2.1.1 Increasing incidence of chronic diseases 68 5.2.1.2 Growing focus on preventive healthcare 69 5.2.1.3 Rising need to curb healthcare cost 69 5.2.1.4 Surge in venture capital investments 70 5.2.1.5 Benefits of digital therapeutics 71 5.2.1.5.1 Ability to induce behavioral change 71 5.2.1.5.2 Improved drug adherence 71 5.2.1.5.3 Patient convenience and user-friendly 72 5.2.2 RESTRAINTS 72 5.2.2.1 Data privacy concerns 72 5.2.3 OPPORTUNITIES 72 5.2.3.1 High growth potential of emerging markets 72 5.2.3.2 Large undiagnosed and untreated population 73 5.2.4 CHALLENGES 73 5.2.4.1 Unstable pricing models 73 5.2.4.2 Reluctance among patients for DTx adoption 74 5.2.4.3 Limited awareness in emerging economies 74 5.2.4.4 Resistance from traditional healthcare providers 74 5.3 INDUSTRY TRENDS 75 5.3.1 VIRTUAL REALITY 75 5.3.2 RISING DEMAND FOR DIGITAL SOLUTIONS IN CBT 75 5.4 TECHNOLOGY ANALYSIS 76 TABLE 2 TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES 76 5.4.1 MACHINE LEARNING 76 5.4.2 ARTIFICIAL INTELLIGENCE 77 5.4.3 INTERNET OF THINGS 77 5.4.4 BLOCKCHAIN TECHNOLOGY 77 5.4.5 CLOUD COMPUTING 78 5.4.6 DATA ANALYTICS 78 5.4.7 EXTENDED REALITY 78 5.5 VALUE CHAIN ANALYSIS 79 FIGURE 21 DIGITAL THERAPEUTICS MARKET: VALUE CHAIN ANALYSIS 79 5.5.1 RESEARCH & PRODUCT DEVELOPMENT 79 5.5.2 MATERIAL COMPONENTS 79 5.5.3 MANUFACTURERS & DEVELOPERS 80 5.5.4 DISTRIBUTION & SALES 80 5.5.5 END-USER INDUSTRIES 80 5.5.6 POST-SALE SERVICES 80 5.6 ECOSYSTEM ANALYSIS 81 FIGURE 22 ECOSYSTEM MARKET/MAP 81 5.7 PIPELINE PRODUCTS 84 5.8 CASE STUDY ANALYSIS 84 5.8.1 CASE STUDY 1: WELLTHY THERAPEUTICS (INDIA) 84 5.8.2 CASE STUDY 2: HAPPIFY HEALTH (US) 85 5.8.3 CASE STUDY 3: OMADA HEALTH (US) 85 5.9 PORTER’S FIVE FORCES ANALYSIS 85 5.9.1 THREAT OF NEW ENTRANTS 86 5.9.2 BARGAINING POWER OF SUPPLIERS 86 5.9.3 BARGAINING POWER OF BUYERS 86 5.9.4 THREAT OF SUBSTITUTES 87 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 87 5.10 REGULATORY LANDSCAPE 87 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 7 DIGITAL THERAPEUTICS MARKET: REGULATORY DATA NEEDED FOR CLASS II DEVICES 95 5.11 PRICING ANALYSIS 96 5.11.1 COSTS INVOLVED IN DIGITAL THERAPEUTICS 96 5.11.2 INDICATIVE PRICING ANALYSIS, BY KEY PLAYER & COUNTRY 96 TABLE 8 AVERAGE SELLING PRICE OF DIGITAL THERAPEUTIC PRODUCTS, BY COUNTRY 96 5.11.3 INDICATIVE PRICING ANALYSIS OF DIGITAL THERAPEUTICS, BY REGION 97 FIGURE 23 INDICATIVE PRICING ANALYSIS OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION 97 5.12 REIMBURSEMENT SCENARIO 98 TABLE 9 DIGITAL THERAPEUTICS MARKET: GLOBAL COVERAGE DETERMINATION STANDARDS 99 5.13 PATENT ANALYSIS 100 5.13.1 PATENT PUBLICATION TRENDS 100 FIGURE 24 LIST OF MAJOR PATIENTS FOR DIGITAL THERAPEUTICS 100 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 100 FIGURE 25 TOP APPLICANT COUNTRIES FOR DIGITAL THERAPEUTICS PATENTS (JANUARY 2016–NOVEMBER 2023) 101 5.13.3 LIST OF MAJOR PATENTS 101 TABLE 10 KEY PATENTS IN DIGITAL THERAPEUTICS MARKET 101 5.14 KEY CONFERENCES AND EVENTS 102 TABLE 11 DIGITAL THERAPEUTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023−2024) 102 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 103 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 103 FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR SALES CHANNEL 103 TABLE 12 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR SALES CHANNEL, BY RANKING 103 5.15.2 BUYING CRITERIA 104 FIGURE 27 KEY BUYING CRITERIA FOR SALES CHANNEL 104 TABLE 13 KEY BUYING CRITERIA FOR SALES CHANNEL, BY RANKING 104 5.16 REVENUE SHIFT AND NEW REVENUE POCKETS FOR DIGITAL THERAPEUTICS MARKET 104 FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 105 5.17 INVESTMENT LANDSCAPE 105 FIGURE 29 INVESTOR DEALS & FUNDING INITIATIVES FOR DIGITAL THERAPEUTICS (2022) 105 FIGURE 30 TOP FUNDING CATEGORIES FOR DIGITAL HEALTH IN 2021 106 FIGURE 31 MOST VALUED TELEHEALTH & TELEMEDICINE FIRMS IN 2022 (USD BILLION) 106 6 DIGITAL THERAPEUTICS MARKET, BY OFFERING 107 6.1 INTRODUCTION 108 TABLE 14 DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 108 6.2 SOFTWARE/PLATFORMS 108 6.2.1 ABILITY TO PROVIDE SCALABLE SOLUTIONS FOR DEPLOYMENT TO PROPEL MARKET 108 TABLE 15 DIGITAL THERAPEUTICS MARKET FOR SOFTWARE/PLATFORMS, BY REGION, 2021–2028 (USD MILLION) 109 6.3 PROGRAMS 109 6.3.1 INTRODUCTION OF EVIDENCE-BASED THERAPEUTIC PROGRAMS TO SUPPORT MARKET GROWTH 109 TABLE 16 DIGITAL THERAPEUTICS MARKET FOR PROGRAMS, BY REGION, 2021–2028 (USD MILLION) 110 6.4 VIRTUAL REALITY/GAMES 110 6.4.1 RISING DEMAND FOR VR SOLUTIONS TO DRIVE MARKET 110 TABLE 17 DIGITAL THERAPEUTICS MARKET FOR VIRTUAL REALITY/GAMES, BY REGION, 2021–2028 (USD MILLION) 111 7 DIGITAL THERAPEUTICS MARKET, BY APPLICATION 112 7.1 INTRODUCTION 113 TABLE 18 DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113 7.2 TREATMENT/CARE-RELATED APPLICATIONS 113 TABLE 19 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 114 TABLE 20 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 114 7.2.1 DIABETES 115 7.2.1.1 Rising prevalence of diabetes to drive market 115 TABLE 21 DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION) 115 7.2.2 CENTRAL NERVOUS SYSTEM (CNS) DISORDERS 115 TABLE 22 DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 116 TABLE 23 DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY REGION, 2021–2028 (USD MILLION) 116 7.2.2.1 Mental health disorders 116 7.2.2.1.1 Benefits of digital therapeutics in managing mental health disorders to drive R&D 116 TABLE 24 DIGITAL THERAPEUTICS MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2021–2028 (USD MILLION) 117 7.2.2.2 Other CNS disorders 117 TABLE 25 DIGITAL THERAPEUTICS MARKET FOR OTHER CNS DISORDERS, BY REGION, 2021–2028 (USD MILLION) 117 7.2.3 SMOKING CESSATION 118 7.2.3.1 Rising development of mobile applications for nicotine addiction treatment to drive market 118 TABLE 26 DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2021–2028 (USD MILLION) 118 7.2.4 CHRONIC RESPIRATORY DISEASES 118 7.2.4.1 Growing prevalence of COPD and asthma to drive market 118 TABLE 27 DIGITAL THERAPEUTICS MARKET FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2021–2028 (USD MILLION) 119 7.2.5 MUSCULOSKELETAL DISORDERS 119 7.2.5.1 Shortage of physiotherapists to boost demand 119 TABLE 28 DIGITAL THERAPEUTICS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2021–2028 (USD MILLION) 119 7.2.6 CARDIOVASCULAR DISEASES 120 7.2.6.1 High incidence of CVD to propel market 120 TABLE 29 DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION) 120 7.2.7 MEDICATION ADHERENCE 120 7.2.7.1 Rising number of non-adherence cases to propel market 120 TABLE 30 DIGITAL THERAPEUTICS MARKET FOR MEDICATION ADHERENCE, BY REGION, 2021–2028 (USD MILLION) 121 7.2.8 GASTROINTESTINAL DISORDERS 121 7.2.8.1 Rising incidence of IBS and GERD to support market growth 121 TABLE 31 DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2021–2028 (USD MILLION) 121 7.2.9 REHABILITATION & PATIENT CARE 122 7.2.9.1 Increasing focus on development of patient care platforms to drive market 122 TABLE 32 DIGITAL THERAPEUTICS MARKET FOR REHABILITATION & PATIENT CARE, BY REGION, 2021–2028 (USD MILLION) 122 7.2.10 SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT 122 7.2.10.1 Growing focus on behavioral interventions to propel market 122 TABLE 33 DIGITAL THERAPEUTICS MARKET FOR SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT, BY REGION, 2021–2028 (USD MILLION) 123 7.2.11 OTHER TREATMENT/CARE-RELATED APPLICATIONS 123 TABLE 34 DIGITAL THERAPEUTICS MARKET FOR OTHER TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 123 7.3 PREVENTIVE APPLICATIONS 124 TABLE 35 DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 124 TABLE 36 DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 125 7.3.1 PREDIABETES 125 7.3.1.1 Focus on reducing type 2 diabetes to support market growth 125 TABLE 37 DIGITAL THERAPEUTICS MARKET FOR PREDIABETES, BY REGION, 2021–2028 (USD MILLION) 125 7.3.2 OBESITY 126 7.3.2.1 Availability of cost-effective solutions for obesity management to propel market 126 TABLE 38 DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2021–2028 (USD MILLION) 126 7.3.3 NUTRITION 126 7.3.3.1 Sedentary lifestyles and unhealthy diets to boost demand 126 TABLE 39 DIGITAL THERAPEUTICS MARKET FOR NUTRITION, BY REGION, 2021–2028 (USD MILLION) 127 7.3.4 LIFESTYLE MANAGEMENT 127 7.3.4.1 Aim to promote holistic lifestyles to drive market 127 TABLE 40 DIGITAL THERAPEUTICS MARKET FOR LIFESTYLE MANAGEMENT, BY REGION, 2021–2028 (USD MILLION) 127 7.3.5 OTHER PREVENTIVE APPLICATIONS 128 TABLE 41 DIGITAL THERAPEUTICS MARKET FOR OTHER PREVENTIVE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 128 8 DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL 129 8.1 INTRODUCTION 130 TABLE 42 DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 130 8.2 SUBSCRIPTION-BASED MODEL 130 8.2.1 FLEXIBILITY IN PAYMENT OPTIONS TO DRIVE MARKET 130 TABLE 43 DIGITAL THERAPEUTICS MARKET FOR SUBSCRIPTION-BASED MODEL, BY REGION, 2021–2028 (USD MILLION) 131 8.3 ONE-TIME PURCHASE/ANNUAL LICENSING MODEL 131 8.3.1 BENEFITS OF LIMITED RECURRING PAYMENTS TO BOOST DEMAND 131 TABLE 44 DIGITAL THERAPEUTICS MARKET FOR ONE-TIME PURCHASE/ANNUAL LICENSING MODEL, BY REGION, 2021–2028 (USD MILLION) 132 8.4 OUTCOME /VALUE-BASED MODEL 132 8.4.1 RESULT-DRIVEN APPROACH THAT ENHANCES END-USER ENGAGEMENT TO PROPEL MARKET 132 TABLE 45 DIGITAL THERAPEUTICS MARKET FOR OUTCOME/VALUE-BASED MODEL, BY REGION, 2021–2028 (USD MILLION) 133 9 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 134 9.1 INTRODUCTION 135 TABLE 46 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 135 9.2 B2B SALES CHANNEL 135 TABLE 47 DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 135 TABLE 48 DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY REGION, 2021–2028 (USD MILLION) 136 9.2.1 PAYERS 136 9.2.1.1 Significant cost savings to boost demand 136 TABLE 49 DIGITAL THERAPEUTICS MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION) 137 9.2.2 EMPLOYERS 137 9.2.2.1 Rising importance of employee health management to drive market 137 TABLE 50 DIGITAL THERAPEUTICS MARKET FOR EMPLOYERS, BY REGION, 2021–2028 (USD MILLION) 138 9.2.3 PHARMACEUTICAL COMPANIES 138 9.2.3.1 Cross-industry collaborations between start-ups and pharma companies to propel market 138 TABLE 51 DIGITAL THERAPEUTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 139 9.2.4 PROVIDERS 139 9.2.4.1 Advanced patient management and cost-reduction benefits to support market growth 139 TABLE 52 DIGITAL THERAPEUTICS MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 140 9.2.5 OTHER BUYERS 140 TABLE 53 DIGITAL THERAPEUTICS MARKET FOR OTHER BUYERS, BY REGION, 2021–2028 (USD MILLION) 140 9.3 B2C SALES CHANNEL 141 TABLE 54 DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 141 TABLE 55 DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY REGION, 2021–2028 (USD MILLION) 141 9.3.1 CAREGIVERS 142 9.3.1.1 Ability to manage chronic conditions effectively to boost demand 142 TABLE 56 DIGITAL THERAPEUTICS MARKET FOR CAREGIVERS, BY REGION, 2021–2028 (USD MILLION) 142 9.3.2 PATIENTS 142 9.3.2.1 Growing awareness of preventive health to support market 142 TABLE 57 DIGITAL THERAPEUTICS MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION) 143 10 DIGITAL THERAPEUTICS MARKET, BY REGION 144 10.1 INTRODUCTION 145 TABLE 58 DIGITAL THERAPEUTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 145 10.2 NORTH AMERICA 145 FIGURE 32 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SNAPSHOT 146 TABLE 59 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147 TABLE 60 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 147 TABLE 61 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 147 TABLE 62 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148 TABLE 63 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 148 TABLE 64 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 149 TABLE 65 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 149 TABLE 66 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 149 TABLE 67 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 150 TABLE 68 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 150 10.2.1 NORTH AMERICA: RECESSION IMPACT 150 10.2.2 US 151 10.2.2.1 Rising technological advancements to boost demand 151 TABLE 69 US: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 152 TABLE 70 US: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 152 TABLE 71 US: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152 TABLE 72 US: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 153 TABLE 73 US: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 153 TABLE 74 US: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 154 TABLE 75 US: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 154 TABLE 76 US: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 154 TABLE 77 US: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 155 10.2.3 CANADA 155 10.2.3.1 Favorable government initiatives for advanced healthcare solutions to support market growth 155 TABLE 78 CANADA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 156 TABLE 79 CANADA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 156 TABLE 80 CANADA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157 TABLE 81 CANADA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 157 TABLE 82 CANADA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 158 TABLE 83 CANADA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 158 TABLE 84 CANADA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 158 TABLE 85 CANADA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 159 TABLE 86 CANADA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 159 10.3 EUROPE 159 TABLE 87 EUROPE: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160 TABLE 88 EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 160 TABLE 89 EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 161 TABLE 90 EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161 TABLE 91 EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 162 TABLE 92 EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 162 TABLE 93 EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 163 TABLE 94 EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 163 TABLE 95 EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 163 TABLE 96 EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 164 10.3.1 EUROPE: RECESSION IMPACT 164 10.3.2 GERMANY 164 10.3.2.1 Rising investments in digital health applications to drive market 164 TABLE 97 GERMANY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 165 TABLE 98 GERMANY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 165 TABLE 99 GERMANY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165 TABLE 100 GERMANY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 166 TABLE 101 GERMANY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 166 TABLE 102 GERMANY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 167 TABLE 103 GERMANY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 167 TABLE 104 GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 167 TABLE 105 GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 168 10.3.3 UK 168 10.3.3.1 High adoption of HCIT solutions to propel market 168 TABLE 106 UK: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 169 TABLE 107 UK: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 169 TABLE 108 UK: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169 TABLE 109 UK: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 170 TABLE 110 UK: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 170 TABLE 111 UK: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 112 UK: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 171 TABLE 113 UK: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 171 TABLE 114 UK: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 172 10.3.4 FRANCE 172 10.3.4.1 Favorable health insurance system to boost demand 172 TABLE 115 FRANCE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 172 TABLE 116 FRANCE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 173 TABLE 117 FRANCE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173 TABLE 118 FRANCE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 174 TABLE 119 FRANCE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 174 TABLE 120 FRANCE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 175 TABLE 121 FRANCE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 175 TABLE 122 FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 175 TABLE 123 FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 176 10.3.5 SPAIN 176 10.3.5.1 Rising incidence of chronic diseases to support market growth 176 TABLE 124 SPAIN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 177 TABLE 125 SPAIN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 177 TABLE 126 SPAIN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177 TABLE 127 SPAIN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 178 TABLE 128 SPAIN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 178 TABLE 129 SPAIN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 179 TABLE 130 SPAIN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 179 TABLE 131 SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 179 TABLE 132 SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 180 10.3.6 ITALY 180 10.3.6.1 Increasing focus on preventive care to support market growth 180 TABLE 133 ITALY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 180 TABLE 134 ITALY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 181 TABLE 135 ITALY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181 TABLE 136 ITALY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 182 TABLE 137 ITALY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 182 TABLE 138 ITALY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 183 TABLE 139 ITALY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 183 TABLE 140 ITALY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 183 TABLE 141 ITALY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 184 10.3.7 REST OF EUROPE 184 TABLE 142 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 185 TABLE 143 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 185 TABLE 144 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185 TABLE 145 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 186 TABLE 146 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 186 TABLE 147 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 187 TABLE 148 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 187 TABLE 149 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 187 TABLE 150 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 188 10.4 ASIA PACIFIC 188 TABLE 151 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 188 TABLE 152 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 189 TABLE 153 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 189 TABLE 154 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189 TABLE 155 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 190 TABLE 156 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 190 TABLE 157 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 191 TABLE 158 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 191 TABLE 159 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 191 TABLE 160 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 192 10.4.1 ASIA PACIFIC: RECESSION IMPACT 192 10.4.2 JAPAN 193 10.4.2.1 Rising incidence of diabetes to propel market 193 TABLE 161 JAPAN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 193 TABLE 162 JAPAN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 193 TABLE 163 JAPAN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 194 TABLE 164 JAPAN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 194 TABLE 165 JAPAN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 195 TABLE 166 JAPAN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 195 TABLE 167 JAPAN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 195 TABLE 168 JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 196 TABLE 169 JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 196 10.4.3 CHINA 196 10.4.3.1 Rising investments in application development to propel market 196 TABLE 170 CHINA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 197 TABLE 171 CHINA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 197 TABLE 172 CHINA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197 TABLE 173 CHINA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198 TABLE 174 CHINA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198 TABLE 175 CHINA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 199 TABLE 176 CHINA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 199 TABLE 177 CHINA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 199 TABLE 178 CHINA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 200 10.4.4 INDIA 200 10.4.4.1 Low patient adherence to prescribed treatments to support market growth 200 TABLE 179 INDIA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 200 TABLE 180 INDIA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 201 TABLE 181 INDIA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 201 TABLE 182 INDIA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 202 TABLE 183 INDIA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 202 TABLE 184 INDIA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 203 TABLE 185 INDIA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 203 TABLE 186 INDIA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 203 TABLE 187 INDIA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 204 10.4.5 REST OF ASIA PACIFIC 204 TABLE 188 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 204 TABLE 189 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 205 TABLE 190 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 205 TABLE 191 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 206 TABLE 192 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 206 TABLE 193 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 207 TABLE 194 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 207 TABLE 195 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 207 TABLE 196 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 208
SummaryThe digital therapeutics market is projected to reach USD 21.9 billion by 2028 from USD 6.1 billion in 2023, at a CAGR of 29.1% during the forecast period. The rapid adoption of digital therapeutics is driven by factors such as the increasing number of patients grappling with chronic diseases and escalating investments in this sector. Nonetheless, impediments to market growth include a lack of awareness and access to digital therapeutics programs in developing nations, resistance from traditional healthcare providers, and the existence of uneven payment models. Table of Contents1 INTRODUCTION 401.1 STUDY OBJECTIVES 40 1.2 MARKET DEFINITION 40 1.3 INCLUSIONS AND EXCLUSIONS 40 1.4 MARKET SCOPE 41 1.4.1 MARKETS COVERED 41 1.4.2 YEARS CONSIDERED 42 1.4.3 CURRENCY CONSIDERED 42 1.5 STAKEHOLDERS 42 1.6 RESEARCH LIMITATIONS 43 1.7 SUMMARY OF CHANGES 43 1.8 RECESSION IMPACT 44 2 RESEARCH METHODOLOGY 45 2.1 RESEARCH DATA 45 FIGURE 1 RESEARCH DESIGN 45 2.1.1 SECONDARY DATA 46 2.1.1.1 Key data from secondary sources 47 2.1.2 PRIMARY DATA 47 FIGURE 2 PRIMARY SOURCES 47 2.1.2.1 Key data from primary sources 48 2.1.2.2 Key industry insights 49 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 50 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY TYPE OF BUYER AND REGION 50 2.2 MARKET SIZE ESTIMATION 51 2.2.1 BOTTOM-UP APPROACH 51 2.2.1.1 Approach 1: Revenue mapping-based estimation 51 FIGURE 5 DIGITAL THERAPEUTICS: REVENUE MAPPING-BASED ESTIMATION 52 2.2.1.2 Approach 2: Buyer adoption-based estimation 52 FIGURE 6 DIGITAL THERAPEUTICS ESTIMATION: BUYER ADOPTION-BASED ESTIMATION 52 2.2.2 TOP-DOWN APPROACH: PENETRATION RATE-BASED MARKET SIZE ESTIMATION 53 FIGURE 7 PENETRATION RATE-BASED MARKET ESTIMATION 53 2.2.3 GROWTH FORECAST 53 TABLE 1 IMPACT ANALYSIS 54 FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 55 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 56 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 56 FIGURE 10 DATA TRIANGULATION METHODOLOGY 57 2.4 ASSUMPTIONS 57 2.5 RISK ASSESSMENT 58 3 EXECUTIVE SUMMARY 59 FIGURE 11 DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2023 VS. 2028 (USD MILLION) 59 FIGURE 12 DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2023 VS. 2028 (USD MILLION) 60 FIGURE 13 DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60 FIGURE 14 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2023 VS. 2028 (USD MILLION) 61 FIGURE 15 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2023 VS. 2028 (USD MILLION) 62 FIGURE 16 GEOGRAPHICAL SNAPSHOT OF DIGITAL THERAPEUTICS MARKET 63 4 PREMIUM INSIGHTS 64 4.1 DIGITAL THERAPEUTICS MARKET OVERVIEW 64 FIGURE 17 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET 64 4.2 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2023 VS. 2O28 65 FIGURE 18 B2B SALES CHANNEL SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 65 4.3 DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66 FIGURE 19 US TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 66 5 MARKET OVERVIEW 67 5.1 INTRODUCTION 67 5.2 MARKET DYNAMICS 67 FIGURE 20 DIGITAL THERAPEUTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67 5.2.1 DRIVERS 68 5.2.1.1 Increasing incidence of chronic diseases 68 5.2.1.2 Growing focus on preventive healthcare 69 5.2.1.3 Rising need to curb healthcare cost 69 5.2.1.4 Surge in venture capital investments 70 5.2.1.5 Benefits of digital therapeutics 71 5.2.1.5.1 Ability to induce behavioral change 71 5.2.1.5.2 Improved drug adherence 71 5.2.1.5.3 Patient convenience and user-friendly 72 5.2.2 RESTRAINTS 72 5.2.2.1 Data privacy concerns 72 5.2.3 OPPORTUNITIES 72 5.2.3.1 High growth potential of emerging markets 72 5.2.3.2 Large undiagnosed and untreated population 73 5.2.4 CHALLENGES 73 5.2.4.1 Unstable pricing models 73 5.2.4.2 Reluctance among patients for DTx adoption 74 5.2.4.3 Limited awareness in emerging economies 74 5.2.4.4 Resistance from traditional healthcare providers 74 5.3 INDUSTRY TRENDS 75 5.3.1 VIRTUAL REALITY 75 5.3.2 RISING DEMAND FOR DIGITAL SOLUTIONS IN CBT 75 5.4 TECHNOLOGY ANALYSIS 76 TABLE 2 TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES 76 5.4.1 MACHINE LEARNING 76 5.4.2 ARTIFICIAL INTELLIGENCE 77 5.4.3 INTERNET OF THINGS 77 5.4.4 BLOCKCHAIN TECHNOLOGY 77 5.4.5 CLOUD COMPUTING 78 5.4.6 DATA ANALYTICS 78 5.4.7 EXTENDED REALITY 78 5.5 VALUE CHAIN ANALYSIS 79 FIGURE 21 DIGITAL THERAPEUTICS MARKET: VALUE CHAIN ANALYSIS 79 5.5.1 RESEARCH & PRODUCT DEVELOPMENT 79 5.5.2 MATERIAL COMPONENTS 79 5.5.3 MANUFACTURERS & DEVELOPERS 80 5.5.4 DISTRIBUTION & SALES 80 5.5.5 END-USER INDUSTRIES 80 5.5.6 POST-SALE SERVICES 80 5.6 ECOSYSTEM ANALYSIS 81 FIGURE 22 ECOSYSTEM MARKET/MAP 81 5.7 PIPELINE PRODUCTS 84 5.8 CASE STUDY ANALYSIS 84 5.8.1 CASE STUDY 1: WELLTHY THERAPEUTICS (INDIA) 84 5.8.2 CASE STUDY 2: HAPPIFY HEALTH (US) 85 5.8.3 CASE STUDY 3: OMADA HEALTH (US) 85 5.9 PORTER’S FIVE FORCES ANALYSIS 85 5.9.1 THREAT OF NEW ENTRANTS 86 5.9.2 BARGAINING POWER OF SUPPLIERS 86 5.9.3 BARGAINING POWER OF BUYERS 86 5.9.4 THREAT OF SUBSTITUTES 87 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 87 5.10 REGULATORY LANDSCAPE 87 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 7 DIGITAL THERAPEUTICS MARKET: REGULATORY DATA NEEDED FOR CLASS II DEVICES 95 5.11 PRICING ANALYSIS 96 5.11.1 COSTS INVOLVED IN DIGITAL THERAPEUTICS 96 5.11.2 INDICATIVE PRICING ANALYSIS, BY KEY PLAYER & COUNTRY 96 TABLE 8 AVERAGE SELLING PRICE OF DIGITAL THERAPEUTIC PRODUCTS, BY COUNTRY 96 5.11.3 INDICATIVE PRICING ANALYSIS OF DIGITAL THERAPEUTICS, BY REGION 97 FIGURE 23 INDICATIVE PRICING ANALYSIS OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION 97 5.12 REIMBURSEMENT SCENARIO 98 TABLE 9 DIGITAL THERAPEUTICS MARKET: GLOBAL COVERAGE DETERMINATION STANDARDS 99 5.13 PATENT ANALYSIS 100 5.13.1 PATENT PUBLICATION TRENDS 100 FIGURE 24 LIST OF MAJOR PATIENTS FOR DIGITAL THERAPEUTICS 100 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 100 FIGURE 25 TOP APPLICANT COUNTRIES FOR DIGITAL THERAPEUTICS PATENTS (JANUARY 2016–NOVEMBER 2023) 101 5.13.3 LIST OF MAJOR PATENTS 101 TABLE 10 KEY PATENTS IN DIGITAL THERAPEUTICS MARKET 101 5.14 KEY CONFERENCES AND EVENTS 102 TABLE 11 DIGITAL THERAPEUTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023−2024) 102 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 103 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 103 FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR SALES CHANNEL 103 TABLE 12 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR SALES CHANNEL, BY RANKING 103 5.15.2 BUYING CRITERIA 104 FIGURE 27 KEY BUYING CRITERIA FOR SALES CHANNEL 104 TABLE 13 KEY BUYING CRITERIA FOR SALES CHANNEL, BY RANKING 104 5.16 REVENUE SHIFT AND NEW REVENUE POCKETS FOR DIGITAL THERAPEUTICS MARKET 104 FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 105 5.17 INVESTMENT LANDSCAPE 105 FIGURE 29 INVESTOR DEALS & FUNDING INITIATIVES FOR DIGITAL THERAPEUTICS (2022) 105 FIGURE 30 TOP FUNDING CATEGORIES FOR DIGITAL HEALTH IN 2021 106 FIGURE 31 MOST VALUED TELEHEALTH & TELEMEDICINE FIRMS IN 2022 (USD BILLION) 106 6 DIGITAL THERAPEUTICS MARKET, BY OFFERING 107 6.1 INTRODUCTION 108 TABLE 14 DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 108 6.2 SOFTWARE/PLATFORMS 108 6.2.1 ABILITY TO PROVIDE SCALABLE SOLUTIONS FOR DEPLOYMENT TO PROPEL MARKET 108 TABLE 15 DIGITAL THERAPEUTICS MARKET FOR SOFTWARE/PLATFORMS, BY REGION, 2021–2028 (USD MILLION) 109 6.3 PROGRAMS 109 6.3.1 INTRODUCTION OF EVIDENCE-BASED THERAPEUTIC PROGRAMS TO SUPPORT MARKET GROWTH 109 TABLE 16 DIGITAL THERAPEUTICS MARKET FOR PROGRAMS, BY REGION, 2021–2028 (USD MILLION) 110 6.4 VIRTUAL REALITY/GAMES 110 6.4.1 RISING DEMAND FOR VR SOLUTIONS TO DRIVE MARKET 110 TABLE 17 DIGITAL THERAPEUTICS MARKET FOR VIRTUAL REALITY/GAMES, BY REGION, 2021–2028 (USD MILLION) 111 7 DIGITAL THERAPEUTICS MARKET, BY APPLICATION 112 7.1 INTRODUCTION 113 TABLE 18 DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113 7.2 TREATMENT/CARE-RELATED APPLICATIONS 113 TABLE 19 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 114 TABLE 20 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 114 7.2.1 DIABETES 115 7.2.1.1 Rising prevalence of diabetes to drive market 115 TABLE 21 DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION) 115 7.2.2 CENTRAL NERVOUS SYSTEM (CNS) DISORDERS 115 TABLE 22 DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 116 TABLE 23 DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY REGION, 2021–2028 (USD MILLION) 116 7.2.2.1 Mental health disorders 116 7.2.2.1.1 Benefits of digital therapeutics in managing mental health disorders to drive R&D 116 TABLE 24 DIGITAL THERAPEUTICS MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2021–2028 (USD MILLION) 117 7.2.2.2 Other CNS disorders 117 TABLE 25 DIGITAL THERAPEUTICS MARKET FOR OTHER CNS DISORDERS, BY REGION, 2021–2028 (USD MILLION) 117 7.2.3 SMOKING CESSATION 118 7.2.3.1 Rising development of mobile applications for nicotine addiction treatment to drive market 118 TABLE 26 DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2021–2028 (USD MILLION) 118 7.2.4 CHRONIC RESPIRATORY DISEASES 118 7.2.4.1 Growing prevalence of COPD and asthma to drive market 118 TABLE 27 DIGITAL THERAPEUTICS MARKET FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2021–2028 (USD MILLION) 119 7.2.5 MUSCULOSKELETAL DISORDERS 119 7.2.5.1 Shortage of physiotherapists to boost demand 119 TABLE 28 DIGITAL THERAPEUTICS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2021–2028 (USD MILLION) 119 7.2.6 CARDIOVASCULAR DISEASES 120 7.2.6.1 High incidence of CVD to propel market 120 TABLE 29 DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION) 120 7.2.7 MEDICATION ADHERENCE 120 7.2.7.1 Rising number of non-adherence cases to propel market 120 TABLE 30 DIGITAL THERAPEUTICS MARKET FOR MEDICATION ADHERENCE, BY REGION, 2021–2028 (USD MILLION) 121 7.2.8 GASTROINTESTINAL DISORDERS 121 7.2.8.1 Rising incidence of IBS and GERD to support market growth 121 TABLE 31 DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2021–2028 (USD MILLION) 121 7.2.9 REHABILITATION & PATIENT CARE 122 7.2.9.1 Increasing focus on development of patient care platforms to drive market 122 TABLE 32 DIGITAL THERAPEUTICS MARKET FOR REHABILITATION & PATIENT CARE, BY REGION, 2021–2028 (USD MILLION) 122 7.2.10 SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT 122 7.2.10.1 Growing focus on behavioral interventions to propel market 122 TABLE 33 DIGITAL THERAPEUTICS MARKET FOR SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT, BY REGION, 2021–2028 (USD MILLION) 123 7.2.11 OTHER TREATMENT/CARE-RELATED APPLICATIONS 123 TABLE 34 DIGITAL THERAPEUTICS MARKET FOR OTHER TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 123 7.3 PREVENTIVE APPLICATIONS 124 TABLE 35 DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 124 TABLE 36 DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 125 7.3.1 PREDIABETES 125 7.3.1.1 Focus on reducing type 2 diabetes to support market growth 125 TABLE 37 DIGITAL THERAPEUTICS MARKET FOR PREDIABETES, BY REGION, 2021–2028 (USD MILLION) 125 7.3.2 OBESITY 126 7.3.2.1 Availability of cost-effective solutions for obesity management to propel market 126 TABLE 38 DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2021–2028 (USD MILLION) 126 7.3.3 NUTRITION 126 7.3.3.1 Sedentary lifestyles and unhealthy diets to boost demand 126 TABLE 39 DIGITAL THERAPEUTICS MARKET FOR NUTRITION, BY REGION, 2021–2028 (USD MILLION) 127 7.3.4 LIFESTYLE MANAGEMENT 127 7.3.4.1 Aim to promote holistic lifestyles to drive market 127 TABLE 40 DIGITAL THERAPEUTICS MARKET FOR LIFESTYLE MANAGEMENT, BY REGION, 2021–2028 (USD MILLION) 127 7.3.5 OTHER PREVENTIVE APPLICATIONS 128 TABLE 41 DIGITAL THERAPEUTICS MARKET FOR OTHER PREVENTIVE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 128 8 DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL 129 8.1 INTRODUCTION 130 TABLE 42 DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 130 8.2 SUBSCRIPTION-BASED MODEL 130 8.2.1 FLEXIBILITY IN PAYMENT OPTIONS TO DRIVE MARKET 130 TABLE 43 DIGITAL THERAPEUTICS MARKET FOR SUBSCRIPTION-BASED MODEL, BY REGION, 2021–2028 (USD MILLION) 131 8.3 ONE-TIME PURCHASE/ANNUAL LICENSING MODEL 131 8.3.1 BENEFITS OF LIMITED RECURRING PAYMENTS TO BOOST DEMAND 131 TABLE 44 DIGITAL THERAPEUTICS MARKET FOR ONE-TIME PURCHASE/ANNUAL LICENSING MODEL, BY REGION, 2021–2028 (USD MILLION) 132 8.4 OUTCOME /VALUE-BASED MODEL 132 8.4.1 RESULT-DRIVEN APPROACH THAT ENHANCES END-USER ENGAGEMENT TO PROPEL MARKET 132 TABLE 45 DIGITAL THERAPEUTICS MARKET FOR OUTCOME/VALUE-BASED MODEL, BY REGION, 2021–2028 (USD MILLION) 133 9 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 134 9.1 INTRODUCTION 135 TABLE 46 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 135 9.2 B2B SALES CHANNEL 135 TABLE 47 DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 135 TABLE 48 DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY REGION, 2021–2028 (USD MILLION) 136 9.2.1 PAYERS 136 9.2.1.1 Significant cost savings to boost demand 136 TABLE 49 DIGITAL THERAPEUTICS MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION) 137 9.2.2 EMPLOYERS 137 9.2.2.1 Rising importance of employee health management to drive market 137 TABLE 50 DIGITAL THERAPEUTICS MARKET FOR EMPLOYERS, BY REGION, 2021–2028 (USD MILLION) 138 9.2.3 PHARMACEUTICAL COMPANIES 138 9.2.3.1 Cross-industry collaborations between start-ups and pharma companies to propel market 138 TABLE 51 DIGITAL THERAPEUTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 139 9.2.4 PROVIDERS 139 9.2.4.1 Advanced patient management and cost-reduction benefits to support market growth 139 TABLE 52 DIGITAL THERAPEUTICS MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 140 9.2.5 OTHER BUYERS 140 TABLE 53 DIGITAL THERAPEUTICS MARKET FOR OTHER BUYERS, BY REGION, 2021–2028 (USD MILLION) 140 9.3 B2C SALES CHANNEL 141 TABLE 54 DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 141 TABLE 55 DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY REGION, 2021–2028 (USD MILLION) 141 9.3.1 CAREGIVERS 142 9.3.1.1 Ability to manage chronic conditions effectively to boost demand 142 TABLE 56 DIGITAL THERAPEUTICS MARKET FOR CAREGIVERS, BY REGION, 2021–2028 (USD MILLION) 142 9.3.2 PATIENTS 142 9.3.2.1 Growing awareness of preventive health to support market 142 TABLE 57 DIGITAL THERAPEUTICS MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION) 143 10 DIGITAL THERAPEUTICS MARKET, BY REGION 144 10.1 INTRODUCTION 145 TABLE 58 DIGITAL THERAPEUTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 145 10.2 NORTH AMERICA 145 FIGURE 32 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SNAPSHOT 146 TABLE 59 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147 TABLE 60 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 147 TABLE 61 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 147 TABLE 62 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148 TABLE 63 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 148 TABLE 64 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 149 TABLE 65 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 149 TABLE 66 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 149 TABLE 67 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 150 TABLE 68 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 150 10.2.1 NORTH AMERICA: RECESSION IMPACT 150 10.2.2 US 151 10.2.2.1 Rising technological advancements to boost demand 151 TABLE 69 US: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 152 TABLE 70 US: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 152 TABLE 71 US: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152 TABLE 72 US: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 153 TABLE 73 US: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 153 TABLE 74 US: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 154 TABLE 75 US: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 154 TABLE 76 US: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 154 TABLE 77 US: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 155 10.2.3 CANADA 155 10.2.3.1 Favorable government initiatives for advanced healthcare solutions to support market growth 155 TABLE 78 CANADA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 156 TABLE 79 CANADA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 156 TABLE 80 CANADA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157 TABLE 81 CANADA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 157 TABLE 82 CANADA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 158 TABLE 83 CANADA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 158 TABLE 84 CANADA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 158 TABLE 85 CANADA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 159 TABLE 86 CANADA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 159 10.3 EUROPE 159 TABLE 87 EUROPE: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160 TABLE 88 EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 160 TABLE 89 EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 161 TABLE 90 EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161 TABLE 91 EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 162 TABLE 92 EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 162 TABLE 93 EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 163 TABLE 94 EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 163 TABLE 95 EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 163 TABLE 96 EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 164 10.3.1 EUROPE: RECESSION IMPACT 164 10.3.2 GERMANY 164 10.3.2.1 Rising investments in digital health applications to drive market 164 TABLE 97 GERMANY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 165 TABLE 98 GERMANY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 165 TABLE 99 GERMANY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165 TABLE 100 GERMANY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 166 TABLE 101 GERMANY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 166 TABLE 102 GERMANY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 167 TABLE 103 GERMANY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 167 TABLE 104 GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 167 TABLE 105 GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 168 10.3.3 UK 168 10.3.3.1 High adoption of HCIT solutions to propel market 168 TABLE 106 UK: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 169 TABLE 107 UK: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 169 TABLE 108 UK: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169 TABLE 109 UK: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 170 TABLE 110 UK: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 170 TABLE 111 UK: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 112 UK: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 171 TABLE 113 UK: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 171 TABLE 114 UK: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 172 10.3.4 FRANCE 172 10.3.4.1 Favorable health insurance system to boost demand 172 TABLE 115 FRANCE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 172 TABLE 116 FRANCE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 173 TABLE 117 FRANCE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173 TABLE 118 FRANCE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 174 TABLE 119 FRANCE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 174 TABLE 120 FRANCE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 175 TABLE 121 FRANCE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 175 TABLE 122 FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 175 TABLE 123 FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 176 10.3.5 SPAIN 176 10.3.5.1 Rising incidence of chronic diseases to support market growth 176 TABLE 124 SPAIN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 177 TABLE 125 SPAIN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 177 TABLE 126 SPAIN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177 TABLE 127 SPAIN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 178 TABLE 128 SPAIN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 178 TABLE 129 SPAIN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 179 TABLE 130 SPAIN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 179 TABLE 131 SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 179 TABLE 132 SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 180 10.3.6 ITALY 180 10.3.6.1 Increasing focus on preventive care to support market growth 180 TABLE 133 ITALY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 180 TABLE 134 ITALY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 181 TABLE 135 ITALY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181 TABLE 136 ITALY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 182 TABLE 137 ITALY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 182 TABLE 138 ITALY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 183 TABLE 139 ITALY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 183 TABLE 140 ITALY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 183 TABLE 141 ITALY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 184 10.3.7 REST OF EUROPE 184 TABLE 142 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 185 TABLE 143 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 185 TABLE 144 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185 TABLE 145 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 186 TABLE 146 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 186 TABLE 147 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 187 TABLE 148 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 187 TABLE 149 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 187 TABLE 150 REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 188 10.4 ASIA PACIFIC 188 TABLE 151 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 188 TABLE 152 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 189 TABLE 153 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 189 TABLE 154 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189 TABLE 155 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 190 TABLE 156 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 190 TABLE 157 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 191 TABLE 158 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 191 TABLE 159 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 191 TABLE 160 ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 192 10.4.1 ASIA PACIFIC: RECESSION IMPACT 192 10.4.2 JAPAN 193 10.4.2.1 Rising incidence of diabetes to propel market 193 TABLE 161 JAPAN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 193 TABLE 162 JAPAN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 193 TABLE 163 JAPAN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 194 TABLE 164 JAPAN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 194 TABLE 165 JAPAN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 195 TABLE 166 JAPAN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 195 TABLE 167 JAPAN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 195 TABLE 168 JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 196 TABLE 169 JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 196 10.4.3 CHINA 196 10.4.3.1 Rising investments in application development to propel market 196 TABLE 170 CHINA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 197 TABLE 171 CHINA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 197 TABLE 172 CHINA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197 TABLE 173 CHINA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198 TABLE 174 CHINA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198 TABLE 175 CHINA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 199 TABLE 176 CHINA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 199 TABLE 177 CHINA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 199 TABLE 178 CHINA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 200 10.4.4 INDIA 200 10.4.4.1 Low patient adherence to prescribed treatments to support market growth 200 TABLE 179 INDIA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 200 TABLE 180 INDIA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 201 TABLE 181 INDIA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 201 TABLE 182 INDIA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 202 TABLE 183 INDIA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 202 TABLE 184 INDIA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 203 TABLE 185 INDIA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 203 TABLE 186 INDIA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 203 TABLE 187 INDIA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 204 10.4.5 REST OF ASIA PACIFIC 204 TABLE 188 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021–2028 (USD MILLION) 204 TABLE 189 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 205 TABLE 190 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 205 TABLE 191 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 206 TABLE 192 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 206 TABLE 193 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021–2028 (USD MILLION) 207 TABLE 194 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021–2028 (USD MILLION) 207 TABLE 195 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 207 TABLE 196 REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021–2028 (USD MILLION) 208
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
MarketsandMarkets社のHealthcare IT分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |